Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder Robert Williams, Jr. Sells 1,000,000 Shares

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Robert Williams, Jr. sold 1,000,000 shares of the firm’s stock in a transaction dated Wednesday, June 24th. The stock was sold at an average price of $8.00, for a total value of $8,000,000.00. Following the completion of the sale, the insider directly owned 245,251 shares in the company, valued at $1,962,008. The trade was a 80.31% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Aveanna Healthcare Trading Up 1.9%

AVAH opened at $8.64 on Friday. The business has a 50 day simple moving average of $7.14 and a two-hundred day simple moving average of $7.58. The firm has a market capitalization of $1.88 billion, a price-to-earnings ratio of 7.32, a PEG ratio of 0.88 and a beta of 1.93. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47. Aveanna Healthcare Holdings Inc. has a one year low of $3.73 and a one year high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a return on equity of 124.68% and a net margin of 10.37%.The business had revenue of $647.91 million during the quarter, compared to analysts’ expectations of $613.22 million. The business’s revenue for the quarter was up 15.9% on a year-over-year basis. Analysts predict that Aveanna Healthcare Holdings Inc. will post 0.65 EPS for the current year.

Hedge Funds Weigh In On Aveanna Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the business. AustralianSuper Pty Ltd purchased a new stake in shares of Aveanna Healthcare in the 3rd quarter worth approximately $15,743,000. Vanguard Group Inc. increased its position in Aveanna Healthcare by 38.0% during the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after buying an additional 1,535,351 shares in the last quarter. Algert Global LLC raised its stake in Aveanna Healthcare by 120.1% during the third quarter. Algert Global LLC now owns 1,022,599 shares of the company’s stock valued at $9,070,000 after buying an additional 557,898 shares during the last quarter. Quantbot Technologies LP boosted its holdings in Aveanna Healthcare by 1,220.8% in the third quarter. Quantbot Technologies LP now owns 109,707 shares of the company’s stock worth $973,000 after acquiring an additional 101,401 shares in the last quarter. Finally, UBS Group AG boosted its holdings in Aveanna Healthcare by 149.4% in the fourth quarter. UBS Group AG now owns 394,182 shares of the company’s stock worth $3,220,000 after acquiring an additional 236,152 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently weighed in on AVAH. BMO Capital Markets cut their price target on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a report on Friday, March 20th. Royal Bank Of Canada upgraded shares of Aveanna Healthcare from a “sector perform” rating to an “outperform” rating and set a $10.00 price objective for the company in a report on Wednesday, June 3rd. Raymond James Financial raised shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 target price for the company in a research report on Friday, March 20th. Weiss Ratings cut shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, April 6th. Finally, Truist Financial increased their price target on shares of Aveanna Healthcare from $8.00 to $9.00 and gave the stock a “hold” rating in a research note on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $10.50.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.